Jens Lundgren

Jens Lundgren

Clinical Professor

Member of:

  • Internal medicine: infection medicine

ORCID: 0000-0001-8901-7850

Publication year:
All
31 - 40 out of 689Page size: 10
Sort by: 1st author
  1. Published

    Incidence of abacavir hypersensitivity reactions in euroSIDA

    Bannister, W. P., Friis-Møller, N., Mocroft, A., Viard, J., van Lunzen, J., Kirk, Ole, Gargalianos, P., Bánhegyi, D., Chiesi, A., Lundgren, Jens & Eurosida Study Group, E. S. G., 2008, In: Antiviral Therapy. 13, 5, p. 687-96 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  2. Published

    Transmitted drug resistant HIV-1 and association with virologic and CD4 cell count response to combination antiretroviral therapy in the EuroSIDA Study

    Bannister, W. P., Cozzi-Lepri, A., Clotet, B., Mocroft, A., Kjaer, J., Reiss, P., von Wyl, V., Lazzarin, A., Katlama, C., Phillips, A. N., Ruiz, L., Lundgren, Jens & Eurosida Study Group, E. S. G., 2008, In: J A I D S. 48, 3, p. 324-33 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Regional changes over time in initial virologic response rates to combination antiretroviral therapy across Europe

    Bannister, W. P., Kirk, Ole, Gatell, J. M., Knysz, B., Viard, J., Mens, H., Monforte, A. D., Phillips, A. N., Mocroft, A., Lundgren, Jens & NN, N., 2006, In: J A I D S. 42, 2, p. 229-237 8 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  4. Published

    Comparison of genotypic resistance profiles and virological response between patients starting nevirapine and efavirenz in EuroSIDA

    Bannister, W. P., Ruiz, L., Cozzi-Lepri, A., Mocroft, A., Kirk, Ole, Staszewski, S., Loveday, C., Karlsson, A., Monforte, A. D., Clotet, B., Lundgren, Jens & Eurosida Study Group, E. S. G., 2008, In: AIDS. 22, 3, p. 367-76 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Association of Self-reported Systemic Reactions Following SARS-CoV-2 Vaccination With Immunological Response in the Danish National Cohort Study of Effectiveness and Safety of SARS-CoV-2 Vaccines (ENFORCE)

    ENFORCE Study Group, E. S. G., 2023, In: Open Forum Infectious Diseases. 10, 6, 9 p., ofad248.

    Research output: Contribution to journal › Journal article › Research › peer-review

  6. Published

    Contemporary antiretrovirals and body-mass index: a prospective study of the RESPOND cohort consortium

    Bansi-Matharu, L., Phillips, A., Oprea, C., Grabmeier-Pfistershammer, K., Günthard, H. F., De Wit, S., Guaraldi, G., Vehreschild, J. J., Wit, F., Law, M., Wasmuth, J. C., Chkhartishvili, N., d'Arminio Monforte, A., Fontas, E., Vesterbacka, J., Miro, J. M., Castagna, A., Stephan, C., Llibre, J. M., Neesgaard, B. & 21 others, Greenberg, L., Smith, C., Kirk, Ole, Duvivier, C., Dragovic, G., Lundgren, Jens, Dedes, N., Knudsen, A., Gallant, J., Vannappagari, V., Peters, L., Elbirt, D., Sarcletti, M., Braun, D. L., Necsoi, C., Mussini, C., Muccini, C., Bolokadze, N., Hoy, J., Mocroft, A. & Ryom, L., 1 Nov 2021, In: The lancet. HIV. 8, 11, p. e711-e722 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  7. Published

    Risk factors for antiretroviral therapy (ART) discontinuation in a large multinational trial of early ART initiators

    Bansi-Matharu, L., Loria, G. R., Cole, S. R., Mugerwa, H., Vecino, I., Lundgren, Jens, Pulik, P., Smith, C., Phillips, A. N. & INSIGHT START Study Group, I. S. S. G., 2019, In: AIDS. 33, 8, p. 1385-1390 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Efficacy and Safety of Ensovibep for Adults Hospitalized With COVID-19: A Randomized Controlled Trial

    ACTIV-3/TICO Study Group, A. S. G., 2022, In: Annals of Internal Medicine. 175, 9, p. 1266-1274 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    Global HIV-1 transmitted drug resistance in the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial

    Baxter, J. D., Dunn, D., White, E., Sharma, S., Geretti, A. M., Kozal, M. J., Johnson, M. A., Jacoby, S., Llibre, J. M., Lundgren, Jens & International Network for Strategic Initiatives in Global HIV Trials (INSIGHT) START Study Group, I. N. F. S. I. I. G. H. T. (. S. S. G., Apr 2015, In: HIV Medicine. 16 , suppl 1, p. 77-87 11 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    Transmitted HIV‐1 drug resistance in a large international cohort using next‐generation sequencing: results from the Strategic Timing of Antiretroviral Treatment (START) study

    Baxter, J., Dunn, D., Tostevin, A., Marvig, R., Bennedbæk, M., Cozzi‐lepri, A., Sharma, S., Kozal, M., Gompels, M., Pinto, A. & Lundgren, Jens, 1 May 2021, In: HIV Medicine. 22, 5, p. 360-371 12 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1 2 3 4 5 6 7 8 ...69 Next

ID: 13961